Diversity and inclusion

Diversity and inclusion are pivotal components of the Sustainable Development Goals (SDGs). Primarily, they relate to SDG 10 (Reduced Inequalities) and SDG 5 (Gender Equality), aiming to promote social, economic, and political inclusion and ensure equal opportunities for all, irrespective of gender, age, race, ethnicity, origin, religion, economic status, or disability. Furthermore, diversity and inclusion relate to SDG 4 (Quality Education) by promoting inclusive and equitable quality education. SDG 8 (Decent Work and Economic Growth) also embodies the values of diversity and inclusion, calling for equal pay for work of equal value and promoting safe and inclusive working environments. Ultimately, the pursuit of diversity and inclusion is indispensable for realizing a fair and sustainable world as envisioned by the SDGs.


Transportation Research Part D: Transport and Environment, Volume 103, February 2022

Efficiency, consistency and sufficiency as complementary strategies for sustainable mobility.
Transport emissions play a large role in climate change. Unfortunately, measures to address this risk creating inequalities in access to mobility. This article proposes policy recommendations to reconcile these two problems.
A Comment on improving the health of Artic Indigenous peoples, in the contexts of SDGs 3, 10, and 15, focusing specifically on the launch of a Lancet Commission that aims to present recommendations for addressing health disparities and key challenges in this community and to identify pathways for change.

International Journal of Radiation Oncology Biology Physics, Volume 112, 1 February 2022

Looks at disparities in access to healthcare among Indigenous people.
Advocacy engagement has been at the forefront of National Cancer Institute (NCI) efforts to advance scientific discoveries and transform medical interventions. Nonetheless, the journey for advocates has been uneven. Case in Point: NCI publication affiliation rules of engagement pose unique equity challenges while raising questions about structural representation in biomedical research.
Elsevier, Studies in History and Philosophy of Science, Volume 91, February 2022
Double standards are widespread throughout biomedicine, especially in research on reproductive health. One of the clearest cases of double standards involves the feminine gendering of reproductive responsibility for contraception and the continued lack of highly effective, reversible methods for cisgender men. While the biomedical establishment accepts diversity and inclusion as important social values for clinical trials, their continued use of inequitable standards undermines their ability to challenge unfair social hierarchies by developing male contraception.
Elsevier, Preventive Medicine, Volume 155, February 2022
Contested racial identity— self-identified race not matching socially-assigned race—may be an indication of experiences with racism. We aimed to understand the relationship between contested racial identity and women's health behaviors, health outcomes, and infant health outcomes. We used 2012–2015 Massachusetts Pregnancy Risk Assessment Monitoring System data on 5735 women linked with infants' birth certificates.
Study objective: This scoping review was conducted to collate and summarize the published research literature addressing sexual and gender minority care in the emergency department (ED). Methods: Using PRISMA-ScR criteria, an electronic search was conducted of CINAHL, Embase, Ovid Medline, and Web of Science for all studies that were published after 1995 involving sexual and gender minorities, throughout all life stages, presenting to an ED. We excluded non-US and Canadian studies and editorials.

Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in the United States. Despite increased screening options and state-of-art treatments offered in clinics, racial differences remain in CRC. African Americans (AAs) are disproportionately affected by the disease; the incidence and mortality are higher in AAs than Caucasian Americans (CAs). At the time of diagnosis, AAs more often present with advanced stages and aggressive CRCs, primarily accounting for the racial differences in therapeutic outcomes and mortality.

This Article supports SDGs 3 and 10 by assessing SARS-CoV-2 incidence in six ethnic groups in Amsterdam, and showing that incidence was highest in the largest minority ethnic groups. The findings suggest that prevention measures and vaccination should be especially encouraged in these groups.
Evaluates prognostic factors for sex differences in lung cancer survival.